Literature DB >> 24218576

Transmission of multiple system atrophy prions to transgenic mice.

Joel C Watts1, Kurt Giles, Abby Oehler, Lefkos Middleton, David T Dexter, Steve M Gentleman, Stephen J DeArmond, Stanley B Prusiner.   

Abstract

Prions are proteins that adopt alternative conformations, which become self-propagating. Increasing evidence argues that prions feature in the synucleinopathies that include Parkinson's disease, Lewy body dementia, and multiple system atrophy (MSA). Although TgM83(+/+) mice homozygous for a mutant A53T α-synuclein transgene begin developing CNS dysfunction spontaneously at ∼10 mo of age, uninoculated TgM83(+/-) mice (hemizygous for the transgene) remain healthy. To determine whether MSA brains contain α-synuclein prions, we inoculated the TgM83(+/-) mice with brain homogenates from two pathologically confirmed MSA cases. Inoculated TgM83(+/-) mice developed progressive signs of neurologic disease with an incubation period of ∼100 d, whereas the same mice inoculated with brain homogenates from spontaneously ill TgM83(+/+) mice developed neurologic dysfunction in ∼210 d. Brains of MSA-inoculated mice exhibited prominent astrocytic gliosis and microglial activation as well as widespread deposits of phosphorylated α-synuclein that were proteinase K sensitive, detergent insoluble, and formic acid extractable. Our results provide compelling evidence that α-synuclein aggregates formed in the brains of MSA patients are transmissible and, as such, are prions. The MSA prion represents a unique human pathogen that is lethal upon transmission to Tg mice and as such, is reminiscent of the prion causing kuru, which was transmitted to chimpanzees nearly 5 decades ago.

Entities:  

Keywords:  bioluminescence imaging; neurodegeneration; proteinopathies; seeding

Mesh:

Substances:

Year:  2013        PMID: 24218576      PMCID: PMC3845125          DOI: 10.1073/pnas.1318268110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Prion-like acceleration of a synucleinopathy in a transgenic mouse model.

Authors:  Anne-Laure Mougenot; Simon Nicot; Anna Bencsik; Eric Morignat; Jérémy Verchère; Latefa Lakhdar; Stéphane Legastelois; Thierry Baron
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

3.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

4.  Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.

Authors:  Jan Stöhr; Joel C Watts; Zachary L Mensinger; Abby Oehler; Sunny K Grillo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

5.  α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Authors:  Christian Hansen; Elodie Angot; Ann-Louise Bergström; Jennifer A Steiner; Laura Pieri; Gesine Paul; Tiago F Outeiro; Ronald Melki; Pekka Kallunki; Karina Fog; Jia-Yi Li; Patrik Brundin
Journal:  J Clin Invest       Date:  2011-01-18       Impact factor: 14.808

6.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

7.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; N J Cairns; P L Lantos; M Goedert
Journal:  Neurosci Lett       Date:  1998-07-31       Impact factor: 3.046

8.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

Authors:  K Wakabayashi; M Yoshimoto; S Tsuji; H Takahashi
Journal:  Neurosci Lett       Date:  1998-06-19       Impact factor: 3.046

9.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.

Authors:  Paula Desplats; He-Jin Lee; Eun-Jin Bae; Christina Patrick; Edward Rockenstein; Leslie Crews; Brian Spencer; Eliezer Masliah; Seung-Jae Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

Review 10.  Prion-like spread of protein aggregates in neurodegeneration.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  J Exp Med       Date:  2012-05-07       Impact factor: 14.307

View more
  183 in total

Review 1.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

2.  Expanding the prion disease repertoire.

Authors:  Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-01       Impact factor: 11.205

Review 3.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

Review 4.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 5.  The physiological role of α-synuclein and its relationship to Parkinson's Disease.

Authors:  David Sulzer; Robert H Edwards
Journal:  J Neurochem       Date:  2019-07-28       Impact factor: 5.372

6.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Nicholas H McGarvey; Nicola J Rutherford; Carolina Ceballos-Diaz; Janice Robertson; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2014-05       Impact factor: 17.088

7.  Towards authentic transgenic mouse models of heritable PrP prion diseases.

Authors:  Joel C Watts; Kurt Giles; Matthew E C Bourkas; Smita Patel; Abby Oehler; Marta Gavidia; Sumita Bhardwaj; Joanne Lee; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2016-06-28       Impact factor: 17.088

8.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

Review 9.  Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.

Authors:  He-Jin Lee; Eun-Jin Bae; Seung-Jae Lee
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

10.  Propagation of prions causing synucleinopathies in cultured cells.

Authors:  Amanda L Woerman; Jan Stöhr; Atsushi Aoyagi; Ryan Rampersaud; Zuzana Krejciova; Joel C Watts; Takao Ohyama; Smita Patel; Kartika Widjaja; Abby Oehler; David W Sanders; Marc I Diamond; William W Seeley; Lefkos T Middleton; Steve M Gentleman; Daniel A Mordes; Thomas C Südhof; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.